Pregabalin Capsule
Product Images NDC 50228-650

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 50228-650). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pregabalin-caps-100mg-500s-count (Pregabalin Caps 100mg 500s Count)

Label for Pregabalin Capsules 100 mg by ScieGen Pharmaceuticals, Inc. The label states dosage form as capsules, strength 100 mg, and quantity of 500 capsules. It includes storage instructions, a request to dispense Medication Guide, and a barcode. The product is prescription only.*

FDA Label Image

Pregabalin-caps-100mg-90s-count (Pregabalin Caps 100mg 90s Count)

Pregabalin Capsules 100 mg oral capsules label by ScieGen Pharmaceuticals, Inc. The label includes dosing instructions, storage conditions, and a barcode. The package contains 90 capsules and is marked Rx Only. The label emphasizes dispensing the accompanying Medication Guide to patients.*

FDA Label Image

Pregabalin-caps-150mg-500s-count (Pregabalin Caps 150mg 500s Count)

Label for Pregabalin Capsules 150 mg by ScieGen Pharmaceuticals, Inc. The label includes dosage information, storage instructions, a barcode, and states the package contains 500 capsules. It emphasizes dispensing with the accompanying Medication Guide and notes the capsules are prescription only.*

FDA Label Image

Pregabalin-caps-150mg-90s-count (Pregabalin Caps 150mg 90s Count)

Label for Pregabalin Capsules 150 mg by ScieGen Pharmaceuticals, Inc. The label states the capsule strength as 150 mg of pregabalin and indicates a package count of 90 capsules. Storage instructions and a note to dispense accompanying Medication Guide are included. The label includes an NDC number 50228-649-90 and a barcode.*

FDA Label Image

Pregabalin-caps-200mg-500s-count (Pregabalin Caps 200mg 500s Count)

Label for Pregabalin Capsules 200 mg by ScieGen Pharmaceuticals, Inc. The label displays dosage strength, 200 mg, and package quantity, 500 capsules. It includes storage instructions, a barcode, and a notice for dispensing the medication guide to patients. The label states prescription use only and highlights storage temperature guidelines.*

FDA Label Image

Pregabalin-caps-200mg-90s-count (Pregabalin Caps 200mg 90s Count)

Pregabalin Capsules 200 mg oral capsules packaging label from ScieGen Pharmaceuticals, Inc. The label states it contains 90 capsules and includes instructions to dispense the accompanying Medication Guide, storage conditions, and child-resistant container usage. The label also displays the NDC 50228-650-90 and ScieGen Pharmaceuticals logo.*

FDA Label Image

Pregabalin-caps-225mg-500s-count (Pregabalin Caps 225mg 500s Count)

Label for Pregabalin Capsules 225 mg by ScieGen Pharmaceuticals, Inc. The label indicates the product contains 225 mg of pregabalin per capsule and comes in a package of 500 capsules. The label includes storage instructions, dosing advisory to see prescribing information, and a barcode. It also states "Rx Only" and features the ScieGen Pharmaceuticals logo.*

FDA Label Image

Pregabalin-caps-225mg-90s-count (Pregabalin Caps 225mg 90s Count)

Label for Pregabalin Capsules 225 mg by ScieGen Pharmaceuticals, Inc. The label states the strength as 225 mg of pregabalin per capsule. It includes dosage and storage instructions, manufacturer details, a barcode, and the package size of 90 capsules. The label also indicates the product is Rx only and displays the NDC 50228-651-90.*

FDA Label Image

Pregabalin-caps-25mg-500s-count (Pregabalin Caps 25mg 500s Count)

Label for Pregabalin Capsules 25 mg by ScieGen Pharmaceuticals, Inc. The label indicates 500 capsules per container, prescription only. It includes storage instructions, dispensing guidance, a barcode, and the labeler information Hauppauge, NY.*

FDA Label Image

Pregabalin-caps-25mg-90ct (Pregabalin Caps 25mg 90ct)

Label for Pregabalin Capsules 25 mg by ScieGen Pharmaceuticals, Inc. The label states each capsule contains 25 mg of pregabalin and comes in a bottle of 90 capsules. It includes instructions to dispense the accompanying Medication Guide and storage conditions are specified. The label also shows the NDC code 50228-645-90 and Rx only designation.*

FDA Label Image

Pregabalin-caps-300mg-500s-count (Pregabalin Caps 300mg 500s Count)

Label for Pregabalin capsules, 300 mg strength, distributed by ScieGen Pharmaceuticals, Inc. The label includes dosage form as capsules, quantity of 500 capsules, and states Rx only. Storage instructions specify 25°C with allowed excursions. The label also directs to the medication guide and features the NDC code 50228-652-05 with a barcode.*

FDA Label Image

Pregabalin-caps-300mg-90s-count (Pregabalin Caps 300mg 90s Count)

Label for Pregabalin Capsules 300 mg by ScieGen Pharmaceuticals, Inc. The label indicates 90 capsules per bottle. It includes the NDC number 50228-652-90, storage instructions, and a note to dispense the accompanying medication guide. The label also displays a barcode and the ScieGen Pharmaceuticals logo.*

FDA Label Image

Pregabalin-caps-50mg-500s-count (Pregabalin Caps 50mg 500s Count)

Label for Pregabalin 50 mg capsules by ScieGen Pharmaceuticals, Inc. The label states the capsule strength as 50 mg, with a quantity of 500 capsules, and indicates prescription use only. It includes storage instructions at 25°C with permitted excursions and notes dispensing in child-resistant containers, along with a barcode and manufacturer information.*

FDA Label Image

Pregabalin-caps-50mg-90s-count (Pregabalin Caps 50mg 90s Count)

Label for Pregabalin Capsules 50 mg from ScieGen Pharmaceuticals, Inc. The label states each capsule contains 50 mg of pregabalin. It indicates dispensing the accompanying Medication Guide and includes storage instructions. The package contains 90 capsules and is Rx only.*

FDA Label Image

Pregabalin-caps-75mg-500s-count (Pregabalin Caps 75mg 500s Count)

Label for Pregabalin Capsules 75 mg by ScieGen Pharmaceuticals, Inc. The label shows dosage strength of 75 mg, quantity of 500 capsules, and indicates prescription use only. It includes storage instructions, a barcode, and notes to dispense the accompanying Medication Guide.*

FDA Label Image

Pregabalin-caps-75mg-90s-count (Pregabalin Caps 75mg 90s Count)

Label for Pregabalin Capsules, 75 mg strength, manufactured by ScieGen Pharmaceuticals, Inc. The label includes dosage form as capsules, package quantity of 90 capsules, and states the product is Rx only. Storage instructions and a web link for the Medication Guide are also visible, along with the NDC number 50228-647-90 and a barcode.*

FDA Label Image

Figure 1 (Pregabalin Fig01)

A line graph showing percent of patients improved versus percent improvement in pain from baseline. Four lines compare Pregabalin dosed at 25 mg, 100 mg, and 200 mg three times a day, and placebo, illustrating varying degrees of pain improvement among patients.*

FDA Label Image

Figure 2 (Pregabalin Fig02)

A line graph comparing the percent of patients improved by various percentages of pain reduction from baseline for Pregabalin 100 mg three times a day versus placebo. The graph plots percent improvement in pain on the horizontal axis against percent of patients improved on the vertical axis, showing a higher response rate for Pregabalin than placebo.*

FDA Label Image

Figure 3 (Pregabalin Fig03)

A line graph depicting the percent of patients improved by percent improvement in pain from baseline for Pregabalin capsules at 75 mg, 150 mg, and 300 mg taken twice a day, compared to placebo. The x-axis shows percent improvement in pain from baseline, and the y-axis shows the percent of patients improved.*

FDA Label Image

Figure 4 (Pregabalin Fig04)

A line graph comparing the percent of patients improved against the percent improvement in pain from baseline. It shows three lines representing Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, and placebo, illustrating the relative effect of the different dosages and placebo on pain improvement.*

FDA Label Image

Figure 5 (Pregabalin Fig05)

A line graph showing the percent of patients improved versus percent improvement in pain from baseline. The graph compares Pregabalin 100 mg three times a day, Pregabalin 50 mg three times a day, and placebo, with Pregabalin doses showing higher patient improvement percentages than placebo across the pain improvement spectrum.*

FDA Label Image

Figure 6 (Pregabalin Fig06)

This bar graph displays responder rates (%) comparing placebo and various doses of Pregabalin in two studies, Study E1 and Study E3. The x-axis shows different doses and regimens, while the y-axis shows responder rate percentages. Statistically significant increases in responder rates versus placebo are marked. Study E1 presents data for BID dosing at 50 mg/day, 150 mg/day, 300 mg/day, and 600 mg/day; Study E3 shows results for BID at 300 mg/day and TID at 600 mg/day.*

FDA Label Image

Figure 7 (Pregabalin Fig07)

A line graph illustrating seizure reduction as median percent change from baseline across various doses of pregabalin (mg/day). The x-axis represents dose (0 to 600 mg/day) and the y-axis shows seizure reduction percentage (0-60%). Four studies (E1 BD, E2 TID, E3 BD, E3 TID) are plotted with symbols, and significant p-values indicate statistical differences for different doses compared to placebo.*

FDA Label Image

Figure 9 (Pregabalin Fig08)

A line graph showing the percent of patients improved relative to percent improvement in pain from baseline for Pregabalin at doses of 300 mg, 450 mg, and 800 mg daily compared to placebo. The x-axis represents percent improvement in pain from baseline, and the y-axis shows the percent of patients improved, with four distinct lines corresponding to each treatment group.*

FDA Label Image

Figure 10 (Pregabalin Fig09)

A Kaplan-Meier survival curve comparing Pregabalin versus placebo over 180 days. The y-axis shows the estimated percentage of subjects without LTR, and the x-axis shows days. The solid line represents Pregabalin, and the dashed line represents placebo, indicating differences in retention or response over time.*

FDA Label Image

Figure 11 (Pregabalin Fig10)

A line graph comparing the percent of subjects improved from baseline to Week 12 for Pregabalin versus placebo. The y-axis shows the percent of subjects improved from 0 to 100%. The x-axis represents the percent improvement from baseline to Week 12 on a BOCF scale from greater than 0 to 100. The solid line represents Pregabalin, showing a higher percent of subjects improved across the range compared to the placebo represented by a dotted line.*

FDA Label Image

Figure 12 (Pregabalin Fig11)

A line graph showing the percentage of subjects improved on the vertical axis versus the percent improved from baseline to week 16 BOCF on the horizontal axis. Two lines represent data for Pregabalin and Placebo, with Pregabalin showing higher improvement percentages across the range compared to Placebo.*

FDA Label Image

Figure 13 (Pregabalin Fig13)

A bar graph showing responder rates (%) for Pregabalin at different dosages compared to placebo. The x-axis presents placebo and two Pregabalin dosages (2.5 mg/kg/day and 10 mg/kg/day), with respective participant numbers indicated below. The y-axis shows responder rates from 0 to 60%, with bars indicating 22.6% for placebo, 29.1% for 2.5 mg/kg/day, and 40.6% for 10 mg/kg/day.*

FDA Label Image

Cockcroft And Gault Equation (Pregabalin Formula)

This image shows a text formula for calculating creatinine clearance (CLcr) based on age, weight, and serum creatinine, with an adjustment factor for female patients. It is likely part of clinical or dosing information related to Pregabalin capsules by ScieGen Pharmaceuticals, Inc.*

FDA Label Image

Chemical Structure (Pregabalin Str)

Chemical structure of Pregabalin, showing its molecular formula with labeled functional groups including an amino group (NH2) and a carboxyl group (CO2H). The diagram depicts the stereochemistry of the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.